Efficient induction of oligodendrocytes from human embryonic stem cells

Stem Cells

Volumn 25, Issue 2, 2007, Pages 419-424

  Kang, Sang Moon ^a   Myung, Soo Cho ^b   Hyemyung, Seo ^c   Chul, Jong Yoon ^d   Sun, Kyung Oh ^e   Young, Min Choi ^e   Kim, Dong Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Jeil Pharmaceutical Co Ltd   (South Korea)

^c Hanyang University   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Central nervous system disorders; Differentiation; Embryonic stem cells; Myelination; Oligodendrocytes

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; THYROID HORMONE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEMYELINATION; EMBRYO; EMBRYONIC STEM CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; MYELINATED NERVE; NERVE CELL; NERVE FIBER; OLIGODENDROGLIA; STEM CELL;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HIPPOCAMPUS; HUMANS; NEURONS; OLIGODENDROGLIA; RATS;

RATTUS;

EID: 33846909499     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0482     Document Type: Article

References (36)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981;78:7634-7638.
3. Thomson JA, Itskovitz-elder J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147
4. Miller RH. Oligodendrocyte origins. Trends Neurosci 1996;19:92-96.
5. Keirstead HS, Blakemore WF. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol 1999;468:183-197.
6. McDonald JW, Becker D, Holekamp TF et al. Repair of the injured spinal cord and the potential of embryonic stem cell transplantation. J Neurotrauma 2004;21:383-393.
7. Zhang SC, Duncan ID. Remyelination and restoration of axonal function by glial cell transplantation. Prog Brain Res 2000;127:515-533.
8. Nistor GI, Totoiu MO, Haque N et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005;49:385-396.
9. Oh SK, Kim HS, Ahn HJ et al. Derivation and characterization of new human embryonic stem cell lines, SNUhES1, SNUhES2 and SNUhES3. STEM CELLS 2005;23:211-219.
10. Brustle O, Jones KN, Learish RD et al. Embryonic Stem Cell-Derived Glial Precursors: A Source of Myelinating Transplants. Science 1999;285:754-755.
11. Okabe S, Forsberg-Nilsson K, Spiro AC et al. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 1996;59:89-102.
12. Zhang SC, Wering M, Duncan ID et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1117-1118.
13. Barberi T, Klibenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200-1207.
14. Billon N, Jolicoeur C, Ying QL et al. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cel Sci 2002;21:6452-6450.
15. Kim DW, Chung SM, Hwang MK et al. Stromal cell-derived inducing activity, Nurr 1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. STEM CELLS 2006;24:557-567.
16. Ruffini F, Arobour N, Blain M et al. Distinctive properties of human adult brain-derived myelin progenitor cells. Am J Pathol 2004;165:2167-2175.
17. Itsokovitz-Eldor J, Schuldiner M, Karsenti D et al. Differentiation of Human embryonic stem cells into embryoid bodies compromising the three germ layers. Mol Med 2000;6:88-95.
18. Dotti CG, Sullivan CA, Banker GA. The establishment of polarity by hippocampal neurons in culture. J Neurosci 1988;8:1454-1468.
19. Rubio N, Rodriguez R, Arevalo MA. In vitro myelination by oligodendrocyte precursor cells transfected with the Neurotrophin-3 gene. Glia 2004;47:78-87.
20. Yan Y, Yang D, Zarnowska ED et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. STEM CELLS 2005;23:781-790.
21. Park CH, Min YK, Lee JY et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 2005;92:1265-1276.
22. Nakafuku M, Nakamura S. Establishment and characterization of a multipotential neural cell line that can conditionally generate neurons, astrocytes, and oligodendrocytes in vitro. J Neurosci Res 1995;41:153-168.
23. Baron W, Metz B, Bansal R et al. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 2000;15:314-329.
24. Woodruff RH, Franklin RJ. Growth factors and remyelination in the CNS. Histol Histopathol 1997;12:459-466.
25. McMorris FA, McKinnon RD. Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 1996;6:313-329.
26. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983;303:390-396.
27. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-343.
28. Reubinoff BE, Itsykson P, Turetsky T et al. Neural progenitors from human embryonic stem cells. Nature 2001;19:1134-1140.
29. Durand B, Raff M. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 2000;22:64-71.
30. Cai Z, Pang Y, Xiao F et al. Chronic ischemia preferentially causes white matter injury in the neonatal rat brain. Brain Res 2001;898:126-135.
31. Zhang SC. Defining glial cells during CNS development. Nat Rev Neurosci 2001;2:840-843.
32. Martin S, Hans-Peter H. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002;68:361-376.
33. Martin ES. Repairing the injured spinal cord. Science 2002;295:1029-1031.
34. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705.
35. Liu S, Qu Y, Stewart TJ et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 2000;97:6126-6131.
36. McDonald JW, Liu XZ, Qu Y et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999;5:1410-1412.